Copyright Reports & Markets. All rights reserved.

Global Vaccine Testing Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Vaccine Testing Service by Type
    • 1.3.1 Overview: Global Vaccine Testing Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Vaccine Testing Service Consumption Value Market Share by Type in 2025
    • 1.3.3 Physical and Chemical Testing
    • 1.3.4 Microbial Detection
    • 1.3.5 Immunological Testing
    • 1.3.6 Others
  • 1.4 Global Vaccine Testing Service Market by Application
    • 1.4.1 Overview: Global Vaccine Testing Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Inactivated Vaccine
    • 1.4.3 Subunit Vaccine
    • 1.4.4 Toxoid Vaccine
    • 1.4.5 mRNA Vaccine
    • 1.4.6 Viral Vector Vaccine
    • 1.4.7 Others
  • 1.5 Global Vaccine Testing Service Market Size & Forecast
  • 1.6 Global Vaccine Testing Service Market Size and Forecast by Region
    • 1.6.1 Global Vaccine Testing Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Vaccine Testing Service Market Size by Region, (2021-2032)
    • 1.6.3 North America Vaccine Testing Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Vaccine Testing Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Vaccine Testing Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America Vaccine Testing Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Vaccine Testing Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 RSSL
    • 2.1.1 RSSL Details
    • 2.1.2 RSSL Major Business
    • 2.1.3 RSSL Vaccine Testing Service Product and Solutions
    • 2.1.4 RSSL Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 RSSL Recent Developments and Future Plans
  • 2.2 Labcorp Drug Development
    • 2.2.1 Labcorp Drug Development Details
    • 2.2.2 Labcorp Drug Development Major Business
    • 2.2.3 Labcorp Drug Development Vaccine Testing Service Product and Solutions
    • 2.2.4 Labcorp Drug Development Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Labcorp Drug Development Recent Developments and Future Plans
  • 2.3 Nexelis
    • 2.3.1 Nexelis Details
    • 2.3.2 Nexelis Major Business
    • 2.3.3 Nexelis Vaccine Testing Service Product and Solutions
    • 2.3.4 Nexelis Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Nexelis Recent Developments and Future Plans
  • 2.4 Charles River Laboratories
    • 2.4.1 Charles River Laboratories Details
    • 2.4.2 Charles River Laboratories Major Business
    • 2.4.3 Charles River Laboratories Vaccine Testing Service Product and Solutions
    • 2.4.4 Charles River Laboratories Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.5 PPD
    • 2.5.1 PPD Details
    • 2.5.2 PPD Major Business
    • 2.5.3 PPD Vaccine Testing Service Product and Solutions
    • 2.5.4 PPD Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 PPD Recent Developments and Future Plans
  • 2.6 WuXi Biologics
    • 2.6.1 WuXi Biologics Details
    • 2.6.2 WuXi Biologics Major Business
    • 2.6.3 WuXi Biologics Vaccine Testing Service Product and Solutions
    • 2.6.4 WuXi Biologics Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 WuXi Biologics Recent Developments and Future Plans
  • 2.7 NIBSC
    • 2.7.1 NIBSC Details
    • 2.7.2 NIBSC Major Business
    • 2.7.3 NIBSC Vaccine Testing Service Product and Solutions
    • 2.7.4 NIBSC Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 NIBSC Recent Developments and Future Plans
  • 2.8 Valneva
    • 2.8.1 Valneva Details
    • 2.8.2 Valneva Major Business
    • 2.8.3 Valneva Vaccine Testing Service Product and Solutions
    • 2.8.4 Valneva Vaccine Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Valneva Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Vaccine Testing Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Vaccine Testing Service by Company Revenue
    • 3.2.2 Top 3 Vaccine Testing Service Players Market Share in 2025
    • 3.2.3 Top 6 Vaccine Testing Service Players Market Share in 2025
  • 3.3 Vaccine Testing Service Market: Overall Company Footprint Analysis
    • 3.3.1 Vaccine Testing Service Market: Region Footprint
    • 3.3.2 Vaccine Testing Service Market: Company Product Type Footprint
    • 3.3.3 Vaccine Testing Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Vaccine Testing Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Vaccine Testing Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Vaccine Testing Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Vaccine Testing Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Vaccine Testing Service Consumption Value by Type (2021-2032)
  • 6.2 North America Vaccine Testing Service Market Size by Application (2021-2032)
  • 6.3 North America Vaccine Testing Service Market Size by Country
    • 6.3.1 North America Vaccine Testing Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Vaccine Testing Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Vaccine Testing Service Consumption Value by Type (2021-2032)
  • 7.2 Europe Vaccine Testing Service Consumption Value by Application (2021-2032)
  • 7.3 Europe Vaccine Testing Service Market Size by Country
    • 7.3.1 Europe Vaccine Testing Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 7.3.3 France Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Vaccine Testing Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Vaccine Testing Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Vaccine Testing Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Vaccine Testing Service Market Size by Region
    • 8.3.1 Asia-Pacific Vaccine Testing Service Consumption Value by Region (2021-2032)
    • 8.3.2 China Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 8.3.5 India Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Vaccine Testing Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Vaccine Testing Service Consumption Value by Type (2021-2032)
  • 9.2 South America Vaccine Testing Service Consumption Value by Application (2021-2032)
  • 9.3 South America Vaccine Testing Service Market Size by Country
    • 9.3.1 South America Vaccine Testing Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Vaccine Testing Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Vaccine Testing Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Vaccine Testing Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Vaccine Testing Service Market Size by Country
    • 10.3.1 Middle East & Africa Vaccine Testing Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Vaccine Testing Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Vaccine Testing Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Vaccine Testing Service Market Drivers
  • 11.2 Vaccine Testing Service Market Restraints
  • 11.3 Vaccine Testing Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Vaccine Testing Service Industry Chain
  • 12.2 Vaccine Testing Service Upstream Analysis
  • 12.3 Vaccine Testing Service Midstream Analysis
  • 12.4 Vaccine Testing Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Vaccine Testing Service market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Vaccine Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Vaccine Testing Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Vaccine Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Vaccine Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Vaccine Testing Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Vaccine Testing Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Vaccine Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RSSL, Labcorp Drug Development, Nexelis, Charles River Laboratories, PPD, WuXi Biologics, NIBSC, Valneva, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Vaccine Testing Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Physical and Chemical Testing
    Microbial Detection
    Immunological Testing
    Others
    Market segment by Application
    Inactivated Vaccine
    Subunit Vaccine
    Toxoid Vaccine
    mRNA Vaccine
    Viral Vector Vaccine
    Others
    Market segment by players, this report covers
    RSSL
    Labcorp Drug Development
    Nexelis
    Charles River Laboratories
    PPD
    WuXi Biologics
    NIBSC
    Valneva
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Vaccine Testing Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Vaccine Testing Service, with revenue, gross margin, and global market share of Vaccine Testing Service from 2021 to 2026.
    Chapter 3, the Vaccine Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Vaccine Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Vaccine Testing Service.
    Chapter 13, to describe Vaccine Testing Service research findings and conclusion.

    Buy now